Pharma Stocks
-
Individual investors invested in OKYO Pharma Limited (NASDAQ:OKYO) up 16% last week, insiders too were rewarded
Key Insights Significant control over OKYO Pharma by individual investors implies that the general public has more power to influence…
Read More » -
Big Pharma Bids And Bright Earnings Drive Stocks Higher
What’s going on here? Pharma stocks had a banner day after Novo Nordisk launched a takeover bid for Metsera and…
Read More » -
Did Alnylam Pharmaceuticals’ (ALNY) Profit Surge and Revenue Upgrade Just Shift Its Investment Narrative?
Alnylam Pharmaceuticals, Inc. recently reported third quarter 2025 results, posting revenues of US$1.25 billion and net income of US$251.08 million,…
Read More » -
What to Look Out for
The market expects Amphastar Pharmaceuticals (AMPH) to deliver a year-over-year decline in earnings on lower revenues when it reports results…
Read More » -
Eagle Pharmaceuticals Extends Rights Plan to 2026, 10% Trigger
Eagle Pharmaceuticals (OTCMKTS: EGRX) announced that its Board amended and extended the company’s limited duration stockholder rights…
Read More » -
NIFTY50 opens below 26,000, SENSEX down 227 points as pharma stocks drag; Dr Reddy’s falls 4%
Upstox Securities Pvt. Ltd.: SEBI Registration No. INZ000315837 | NSE TM Code: 13942 | BSE TM Code: 6155 | CDSL…
Read More » -
Analyst Estimates: Here’s What Brokers Think Of Shionogi & Co., Ltd. (TSE:4507) After Its Half-Year Report
Last week saw the newest half-year earnings release from Shionogi & Co., Ltd. (TSE:4507), an important milestone in the company’s…
Read More » -
Will Botanix Pharmaceuticals’ (ASX:BOT) Investor Outreach Reinforce Management Credibility or Raise Fresh Questions?
Botanix Pharmaceuticals recently held a special call to update investors on its quarterly activity report and Sofdra® topical gel launch,…
Read More » -
Assessing Amneal Pharmaceuticals (AMRX) Valuation After Steady Share Price Gains and Growth Initiatives
Amneal Pharmaceuticals (AMRX) shares inched up around 0.4% on Monday, capping a month where the stock climbed more than 4%.…
Read More » -
Assessing Ascendis Pharma (NasdaqGS:ASND) Valuation Following Expanded SKYTROFA Launch for Adult Growth Hormone Deficiency
Ascendis Pharma (NasdaqGS:ASND) just announced that its SKYTROFA (TransCon hGH) is now broadly available in the United States, with expanded…
Read More »